Compile Data Set for Download or QSAR
Report error Found 167 for UniProtKB: P03406
TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288119BDBM288119(Production of 7′-(3-chloro-2-fluorobenzylcar...)
Affinity DataEC50:  0.700nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288127BDBM288127(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  0.700nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288106BDBM288106(Production of Monosodium 7′-(3-chloro-2-fluo...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288125BDBM288125(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288126BDBM288126(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288113BDBM288113(US10087178, Example 31 | US10087178, Example 32 | ...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288115BDBM288115(Production of N-(3-chloro-2-fluorobenzyl)-9′...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288131BDBM288131(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  0.900nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288122BDBM288122(US10087178, Example 40)
Affinity DataEC50:  1nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288124BDBM288124(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...)
Affinity DataEC50:  1nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288128BDBM288128(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  1nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288112BDBM288112(US10087178, Example 30)
Affinity DataEC50:  1.10nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288132BDBM288132(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  1.10nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288121BDBM288121(Production of (E)-4-[7′-(3-chloro-2-fluorobe...)
Affinity DataEC50:  1.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288129BDBM288129(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  1.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288109BDBM288109(Production of N-(3-chloro-2-fluorobenzyl)-9′...)
Affinity DataEC50:  1.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288105BDBM288105(Production of N-(3-chloro-2-fluorobenzyl)-9′...)
Affinity DataEC50:  1.60nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288108BDBM288108(Production of N-(3-chloro-2-fluorobenzyl)-9′...)
Affinity DataEC50:  1.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288172BDBM288172((1S,2S)-N-(2,4- difluorobenzyl)-2'-ethyl-9'- hydro...)
Affinity DataEC50:  1.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288113BDBM288113(US10087178, Example 31 | US10087178, Example 32 | ...)
Affinity DataEC50:  1.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288130BDBM288130(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-(met...)
Affinity DataEC50:  1.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288024BDBM288024(US10087178, Example 6)
Affinity DataEC50:  2nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288107BDBM288107(Production of Monopotassium 7′-(3-chloro-2-f...)
Affinity DataEC50:  2.10nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288173BDBM288173((1S,2S)-N-(2,4- difluorobenzyl)-9'-hydroxy- 2'-iso...)
Affinity DataEC50:  2.20nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288110BDBM288110(Production of Monosodium 7′-(3-chloro-2-fluo...)
Affinity DataEC50:  2.20nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288080BDBM288080(N-(3-chloro-2-fluorobenzyl)- 9'-hydroxy-trans-3- i...)
Affinity DataEC50:  2.30nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288091BDBM288091(N-(2,4-difluorobenzyl)-cis- 3-ethoxy-9'-hydroxy-2'...)
Affinity DataEC50:  2.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288111BDBM288111(Production of Monopotassium 7′-(3-chloro-2-f...)
Affinity DataEC50:  2.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288037BDBM288037(US10087178, Example 18)
Affinity DataEC50:  2.60nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288118BDBM288118(Production of Monopotassium 7′-(3-chloro-2-f...)
Affinity DataEC50:  2.60nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288123BDBM288123(7'-(3-chloro-2- fluorobenzylcarbamoyl)-cis- 3-meth...)
Affinity DataEC50:  2.80nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288171BDBM288171((1S,2S)-N-(2,4- difluorobenzyl)-2'-ethyl-9'- hydro...)
Affinity DataEC50:  2.80nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288022BDBM288022(US10087178, Example 4)
Affinity DataEC50:  2.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288023BDBM288023(US10087178, Example 5)
Affinity DataEC50:  2.90nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288019BDBM288019(US10087178, Example 1)
Affinity DataEC50:  3.10nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288021BDBM288021(US10087178, Example 3)
Affinity DataEC50:  3.20nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288156BDBM288156((1R,2R)-N-(3-chloro-2- fluorobenzyl)-9'-hydroxy-2-...)
Affinity DataEC50:  3.20nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288116BDBM288116(Production of N-(3-chloro-2-fluorobenzyl)-2′...)
Affinity DataEC50:  3.20nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288165BDBM288165((1R,2R)-N7'-(3-chloro-2- fluorobenzyl)-2'-cyclopro...)
Affinity DataEC50:  3.30nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288164BDBM288164((1S,2S)-N7'-(3-chloro-2- fluorobenzyl)-2'-cyclopro...)
Affinity DataEC50:  3.30nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288145BDBM288145((1S,2S)-N7'-(3-chloro-2- fluorobenzyl)-9'-hydroxy-...)
Affinity DataEC50:  3.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288066BDBM288066(N-(3-chloro-2-fluorobenzyl)- trans-3,9'-dihydroxy-...)
Affinity DataEC50:  3.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288178BDBM288178((1R,2R)-N-(3-chloro-2- fluorobenzyl)-2'-ethyl-9'- ...)
Affinity DataEC50:  3.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288036BDBM288036(US10087178, Example 17)
Affinity DataEC50:  3.40nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288087BDBM288087(N-(3-chloro-2-fluorobenzyl)- 2'-ethyl-9'-hydroxy-c...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288152BDBM288152((1R,2R)-N-(3-chloro-2- fluorobenzyl)-2'-ethyl-9'- ...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288060BDBM288060(N-(2,4-difluorobenzyl)-2'- ethyl-9'-hydroxy-cis-3-...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288092BDBM288092(N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-tr...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288079BDBM288079(N-(3-chloro-2-fluorobenzyl)- cis-3-(ethoxymethyl)-...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

TargetProtein Nef(HIV-1)
Japan Tobacco

US Patent
LigandChemical structure of BindingDB Monomer ID 288081BDBM288081(N-(3-chloro-2-fluorobenzyl)- 9'-hydroxy-cis-3-isop...)
Affinity DataEC50:  3.5nMT: 2°CAssay Description:The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/17/2019
Entry Details
US Patent

Displayed 1 to 50 (of 167 total ) | Next | Last >>
Jump to: